원저

자각성 이 명 환자에서 Ginkgo biloba extracts (Ginexin-F)의 제 3상 임상 효과

임현호1, 정근1, 최종욱1
Hyun-Ho Lim1, Keun Chung1, Jong-Ouck Choi1
Author Information & Copyright
1고려대학교 의과대학 이비인후一두경부외과학교실
1Department of Otolaryngology-Head and Neck Surgery, Korea University, College of Medicine

© Copyright 1996 The Busan, Ulsan, Gyeoungnam Branch of Korean Society of Otolaryngology-Head and Neck Surgery. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Published Online: May 31, 2020

ABSTRACT

Tinnitus is an aberrant perception of sound unrelated to an external source of stimulation. Because of inadequate understanding of the etiology, treatment of tinnitus has been disappointing. Various treatment protocols have been attempted for tinnitus including medication, tinnitus masker, psycological counseling, but no single treatment was proven to be the most effective method. Recently Extracts from ginkgo biloba leaf (GBE) has been reported to be effective in treatment of tinnitus. In this clinical study we used GBE for the treatment of tinnitus and evaluated its efficacy and safety. Fourty patients who have idiopathic, subjective tinnitus were divided into two group. Twenty patients were treated with GBE (Ginexin-F) for 3 months, while another twenty patients were treated with adenosin triphosphate disodium (ATP) for same peirod as control group. Nine of 16 patients (56 O had a symptomatic improvement after 3 months trial of Ginexin-F, while control group showed 25% improvement. During the clinical trial there was no significant adverse effect of Ginexin- F except mild gastrointestinal discomfort. With this results we suggest that GBE might be effective and safe drug for treatment of tinnitus of idiopathic origin.

Keywords: Ginkgo biloba extracts; Tinnitus


36권 4호 Quiz 및 정답, 해설

정답 ④

설하신경자극술의 핵심 치료 원리는 설하신경의 내측 분지를 선택적으로 
자극하여 이설근(genioglossus muscle)의 전방 돌출을 유도함으로써 
수면 중 상기도의 기능적 개방성을 유지하는 것이다. 기존 Inspire® 시스템은 
흡기 노력 감지 센서를 이용해 자극을 호흡 주기와 동기화하며, Nyxoah Genio® 
시스템은 양측 설하신경을 동시에 자극하는 무배터리 구조를 채택한 최신 장치이다. 
반면 Ansa cervicalis stimulation은 혀가 아닌 인두 구조물의 미측 견인을 통해 
상기도를 안정화시키는 다른 기전을 가진다.

 

* 당첨자 (1명)

이**    010-****-**61

 

응모해 주신 모든분들께 감사드립니다.

경품은 당첨자분들께 2.20(금)까지 개별 발송해 드리겠습니다.

 

임상이비인후과 편집위원회 


I don't want to open this window for a day.